New nanodevice to improve cancer treatment monitoring
10/28/2014
In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug.
In peripheral squamous cell carcinomas of the lung, prognostic factors identified
10/28/2014
A better survival outcome is associated with low blood levels of squamous cell carcinoma antigen, or absence of tumor invasion either into the space between the lungs and chest wall or into blood...
Mutation might make colorectal, endometrial tumors sensitive to new cancer drugs
10/28/2014
Scientists say they have identified in about 20 percent of colorectal and endometrial cancers a genetic mutation that had been overlooked in recent large, comprehensive gene searches.
Ludwig Oxford researchers have discovered a key mechanism that governs how cells of the epithelia, the soft lining of inner body cavities, shift between a rigid, highly structured and immobile state...
In peripheral squamous cell carcinomas of the lung, prognostic factors identified
10/28/2014
A better survival outcome is associated with low blood levels of squamous cell carcinoma antigen, or absence of tumor invasion either into the space between the lungs and chest wall or into blood...
Toxin-secreting stem cells engineered to treat brain tumors
10/28/2014
Harvard Stem Cell Institute scientists at Massachusetts General Hospital have devised a new way to use stem cells in the fight against brain cancer.
Uncovering the mechanisms of a protein activator involved in promoting colorectal cancer, scientists from Rutgers Cancer Institute of New Jersey demonstrated that a small GTPase enzyme, known as...
Dartmouth study measures breast cancer tumor response to neoadjuvant chemotherapy
10/27/2014
A Dartmouth study suggests that it may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast...
Shortcomings in the management of elderly patients with myelodysplastic syndromes highlighted - UK
10/27/2014
A new Call to Action, has been launched by the MDS UK Patient Support Group and Leukaemia CARE with support from Celgene, reveals that elderly patients in the UK with a rare form of blood cancer...
Stem cells that release cancer-killing toxins offer new brain tumor treatment
10/27/2014
Scientists have made stem cells that produce and secrete cancer-killing toxins without harming the stem cells themselves, and used them to treat mice following brain tumor surgery.